{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T11:52:39Z","timestamp":1781697159642,"version":"3.54.5"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:00:00Z","timestamp":1776470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":60,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004772","name":"Natural Science Foundation of Ningxia Province","doi-asserted-by":"publisher","award":["2024AAC03655"],"award-info":[{"award-number":["2024AAC03655"]}],"id":[{"id":"10.13039\/501100004772","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-46678-5","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T06:54:15Z","timestamp":1776495255000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and validation of an immune-related diagnostic signature for breast cancer bone metastasis"],"prefix":"10.1038","volume":"16","author":[{"given":"Jing","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyong","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningkui","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhua","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiandang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongqiang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,18]]},"reference":[{"issue":"1174","key":"46678_CR1","doi-asserted-by":"publisher","DOI":"10.1093\/bjr\/tqaf148","volume":"98","author":"MMA Elbasheer","year":"2025","unstructured":"Elbasheer, M. M. A., Dodwell, D. & Gathani, T. Understanding global variation in breast cancer mortality. Br. J. Radiol. 98(1174), tqaf148. https:\/\/doi.org\/10.1093\/bjr\/tqaf148 (2025).","journal-title":"Br. J. Radiol."},{"issue":"6","key":"46678_CR2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68(6), 394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492 (2018).","journal-title":"CA Cancer J. Clin."},{"issue":"11","key":"46678_CR3","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1002\/ijc.33114","volume":"147","author":"J Lortet-Tieulent","year":"2020","unstructured":"Lortet-Tieulent, J., Georges, D., Bray, F. & Vaccarella, S. Profiling global cancer incidence and mortality by socioeconomic development. Int. J. Cancer 147(11), 3029\u20133036. https:\/\/doi.org\/10.1002\/ijc.33114 (2020).","journal-title":"Int. J. Cancer"},{"key":"46678_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19040970","author":"AK Basu","year":"2018","unstructured":"Basu, A. K. DNA damage, mutagenesis and cancer. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms19040970 (2018).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"46678_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-022-02272-x","volume":"41","author":"N Kumari","year":"2022","unstructured":"Kumari, N. & Choi, S. H. Tumor-associated macrophages in cancer: Recent advancements in cancer nanoimmunotherapies. J. Exp. Clin. Cancer. Res. 41(1), 68. https:\/\/doi.org\/10.1186\/s13046-022-02272-x (2022).","journal-title":"J. Exp. Clin. Cancer. Res."},{"issue":"1","key":"46678_CR6","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s10585-016-9824-8","volume":"34","author":"AG Ording","year":"2017","unstructured":"Ording, A. G. et al. Site of metastasis and breast cancer mortality: A Danish nationwide registry-based cohort study. Clin. Exp. Metastasis 34(1), 93\u2013101. https:\/\/doi.org\/10.1007\/s10585-016-9824-8 (2017).","journal-title":"Clin. Exp. Metastasis"},{"issue":"1","key":"46678_CR7","doi-asserted-by":"publisher","first-page":"72","DOI":"10.2174\/0115665232283880240301035621","volume":"25","author":"M Araghi","year":"2025","unstructured":"Araghi, M. et al. Efficacy and safety of pembrolizumab monotherapy or combined therapy in patients with metastatic triple-negative breast cancer: A systematic review and meta-analysis of randomized controlled trials. Curr. Gene Ther. 25(1), 72\u201388. https:\/\/doi.org\/10.2174\/0115665232283880240301035621 (2025).","journal-title":"Curr. Gene Ther."},{"issue":"4","key":"46678_CR8","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1093\/annonc\/mdz012","volume":"30","author":"ME Robson","year":"2019","unstructured":"Robson, M. E. et al. OlympiAD final overall survival and tolerability results: Olaparib versus chemotherapy treatment of physician\u2019s choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer. Ann. Oncol. 30(4), 558\u2013566. https:\/\/doi.org\/10.1093\/annonc\/mdz012 (2019).","journal-title":"Ann. Oncol."},{"issue":"1","key":"46678_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-6311-z","volume":"19","author":"R Wang","year":"2019","unstructured":"Wang, R. et al. The clinicopathological features and survival outcomes of patients with different metastatic sites in stage IV breast cancer. BMC Cancer 19(1), 1091. https:\/\/doi.org\/10.1186\/s12885-019-6311-z (2019).","journal-title":"BMC Cancer"},{"issue":"5","key":"46678_CR10","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s10585-019-09983-0","volume":"36","author":"Y Shinoda","year":"2019","unstructured":"Shinoda, Y. et al. Factors related to the quality of life in patients with bone metastases. Clin. Exp. Metastasis 36(5), 441\u2013448. https:\/\/doi.org\/10.1007\/s10585-019-09983-0 (2019).","journal-title":"Clin. Exp. Metastasis"},{"issue":"2","key":"46678_CR11","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s10549-011-1475-5","volume":"129","author":"M Yong","year":"2011","unstructured":"Yong, M. et al. Survival in breast cancer patients with bone metastases and skeletal-related events: A population-based cohort study in Denmark (1999\u20132007). Breast. Cancer. Res. Treat. 129(2), 495\u2013503. https:\/\/doi.org\/10.1007\/s10549-011-1475-5 (2011).","journal-title":"Breast. Cancer. Res. Treat."},{"key":"46678_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14081881","author":"C Louren\u00e7o","year":"2022","unstructured":"Louren\u00e7o, C., Concei\u00e7\u00e3o, F., Jer\u00f3nimo, C., Lamghari, M. & Sousa, D. M. Stress in metastatic breast cancer: To the bone and beyond. Cancers (Basel) https:\/\/doi.org\/10.3390\/cancers14081881 (2022).","journal-title":"Cancers (Basel)"},{"issue":"7","key":"46678_CR13","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucl. Acid. Res. 43(7), e47. https:\/\/doi.org\/10.1093\/nar\/gkv007 (2015).","journal-title":"Nucl. Acid. Res."},{"issue":"22","key":"46678_CR14","doi-asserted-by":"publisher","first-page":"10183","DOI":"10.18632\/aging.102434","volume":"11","author":"C Zhang","year":"2019","unstructured":"Zhang, C. et al. Development and validation of a metastasis-associated prognostic signature based on single-cell RNA-seq in clear cell renal cell carcinoma. Aging (Albany NY) 11(22), 10183\u201310202. https:\/\/doi.org\/10.18632\/aging.102434 (2019).","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"46678_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-07628-0","volume":"20","author":"X Li","year":"2020","unstructured":"Li, X. & Meng, Y. Analyses of metastasis-associated genes in IDH wild-type glioma. BMC Cancer 20(1), 1114. https:\/\/doi.org\/10.1186\/s12885-020-07628-0 (2020).","journal-title":"BMC Cancer"},{"issue":"24","key":"46678_CR16","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000010781","volume":"97","author":"H Tian","year":"2018","unstructured":"Tian, H., Guan, D. & Li, J. Identifying osteosarcoma metastasis associated genes by weighted gene co-expression network analysis (WGCNA). Medicine (Baltimore) 97(24), e10781. https:\/\/doi.org\/10.1097\/MD.0000000000010781 (2018).","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"46678_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-17468-6","volume":"12","author":"H Luan","year":"2022","unstructured":"Luan, H., Jian, L., He, Y., Zhang, T. & Zhou, L. Exploration and validation of metastasis-associated genes for skin cutaneous melanoma. Sci. Rep. 12(1), 13002. https:\/\/doi.org\/10.1038\/s41598-022-17468-6 (2022).","journal-title":"Sci. Rep."},{"key":"46678_CR18","doi-asserted-by":"publisher","DOI":"10.2174\/0118761429263841230926014118","author":"Y Naeimzadeh","year":"2023","unstructured":"Naeimzadeh, Y., Heidari, Z., Razban, V. & Khajeh, S. Deregulated MicroRNAs involved in P53 signaling pathway in breast cancer with focus on triple-negative breast cancer. Pharm. Curr. https:\/\/doi.org\/10.2174\/0118761429263841230926014118 (2023).","journal-title":"Pharm. Curr."},{"key":"46678_CR19","doi-asserted-by":"publisher","DOI":"10.2174\/1874467216666221017122105","author":"M Talebi","year":"2022","unstructured":"Talebi, M., Farkhondeh, T., Harifi-Mood, M. S., Talebi, M. & Samarghandian, S. Mechanistic features and therapeutic implications related to the MiRNAs and Wnt signaling regulatory in breast cancer. Curr. Mol. Pharmacol. https:\/\/doi.org\/10.2174\/1874467216666221017122105 (2022).","journal-title":"Curr. Mol. Pharmacol."},{"issue":"5","key":"46678_CR20","doi-asserted-by":"publisher","first-page":"343","DOI":"10.2174\/0113892029305656240503045154","volume":"25","author":"MS Hussain","year":"2024","unstructured":"Hussain, M. S. et al. Beyond the genome: Deciphering the role of MALAT1 in breast cancer progression. Curr. Genomics 25(5), 343\u2013357. https:\/\/doi.org\/10.2174\/0113892029305656240503045154 (2024).","journal-title":"Curr. Genomics"},{"issue":"9","key":"46678_CR21","doi-asserted-by":"publisher","first-page":"681","DOI":"10.2174\/0109298665322427240906060626","volume":"31","author":"V Torun","year":"2024","unstructured":"Torun, V., Degerli, E. & Cansaran-Duman, D. Revealing the molecular signatures of miR-185-5p on breast cancer cells using proteomic analysis. Protein Pept. Lett. 31(9), 681\u2013695. https:\/\/doi.org\/10.2174\/0109298665322427240906060626 (2024).","journal-title":"Protein Pept. Lett."},{"key":"46678_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.799507","volume":"9","author":"Y Wang","year":"2021","unstructured":"Wang, Y., Wang, Z., Sun, J. & Qian, Y. Identification of HCC subtypes with different prognosis and metabolic patterns based on mitophagy. Front. Cell Dev. Biol. 9, 799507. https:\/\/doi.org\/10.3389\/fcell.2021.799507 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"46678_CR23","doi-asserted-by":"publisher","DOI":"10.2174\/0118761429380394250217093030","volume":"17","author":"S Yan","year":"2024","unstructured":"Yan, S. et al. Exploring the immune-related molecular mechanisms underlying the comorbidity of temporal lobe epilepsy and major depressive disorder through integrated data set analysis. Curr. Mol. Pharmacol. 17, e18761429380394. https:\/\/doi.org\/10.2174\/0118761429380394250217093030 (2024).","journal-title":"Curr. Mol. Pharmacol."},{"key":"46678_CR24","doi-asserted-by":"publisher","unstructured":"Wang, S., Xie, C., Hu, H., Yu, P., Zhong, H., Wang, Y., Shan, L. iTRAQ-based proteomic analysis unveils NCAM1 as a novel regulator in doxorubicin-induced cardiotoxicity and DT-010-exerted cardioprotection. Curr. Proteom. 21, https:\/\/doi.org\/10.2174\/0115734129331758241022113026 (2024).","DOI":"10.2174\/0115734129331758241022113026"},{"issue":"1","key":"46678_CR25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucl. Acid. Res. 28(1), 27\u201330. https:\/\/doi.org\/10.1093\/nar\/28.1.27 (2000).","journal-title":"Nucl. Acid. Res."},{"issue":"11","key":"46678_CR26","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28(11), 1947\u20131951. https:\/\/doi.org\/10.1002\/pro.3715 (2019).","journal-title":"Protein Sci."},{"issue":"D1","key":"46678_CR27","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Kawashima, M. & Ishiguro-Watanabe, M. KEGG for taxonomy-based analysis of pathways and genomes. Nucl. Acid. Res. 51(D1), D587\u2013D592. https:\/\/doi.org\/10.1093\/nar\/gkac963 (2023).","journal-title":"Nucl. Acid. Res."},{"key":"46678_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.599494","volume":"8","author":"S Wang","year":"2020","unstructured":"Wang, S. et al. An Eight-CircRNA assessment model for predicting biochemical recurrence in prostate cancer. Front. Cell Dev. Biol. 8, 599494. https:\/\/doi.org\/10.3389\/fcell.2020.599494 (2020).","journal-title":"Front. Cell Dev. Biol."},{"key":"46678_CR29","doi-asserted-by":"publisher","DOI":"10.2174\/0115734129298587240322073956","author":"X Xiao","year":"2024","unstructured":"Xiao, X., Liu, Y., Huang, Y., Zeng, W. & Luo, Z. Identification of the NF-\u03baB inhibition peptides in asthma from Pheretima aspergillum decoction and formula granules using molecular docking and dynamics simulations. Comb. Chem. High Throughput Screen. https:\/\/doi.org\/10.2174\/0115734129298587240322073956 (2024).","journal-title":"Comb. Chem. High Throughput Screen."},{"issue":"2","key":"46678_CR30","doi-asserted-by":"publisher","first-page":"172","DOI":"10.37349\/etat.2022.00078","volume":"3","author":"A Skolariki","year":"2022","unstructured":"Skolariki, A., D\u2019Costa, J., Little, M. & Lord, S. Role of PI3K\/Akt\/mTOR pathway in mediating endocrine resistance: Concept to clinic. Explor. Target Antitumor Ther. 3(2), 172\u2013199. https:\/\/doi.org\/10.37349\/etat.2022.00078 (2022).","journal-title":"Explor. Target Antitumor Ther."},{"issue":"1","key":"46678_CR31","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13058-021-01462-3","volume":"23","author":"JO Brett","year":"2021","unstructured":"Brett, J. O., Spring, L. M., Bardia, A. & Wander, S. A. ESR1 mutation as an emerging clinical biomarker in metastatic hormone receptor-positive breast cancer. Breast Cancer Res. 23(1), 85. https:\/\/doi.org\/10.1186\/s13058-021-01462-3 (2021) (Published 2021 Aug 15.).","journal-title":"Breast Cancer Res."},{"issue":"13","key":"46678_CR32","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1158\/0008-5472.CAN-18-3418","volume":"79","author":"H Zhang","year":"2019","unstructured":"Zhang, H. et al. Epigenetic regulation of NAMPT by NAMPT-AS drives metastatic progression in Triple-Negative breast cancer. Cancer Res. 79(13), 3347\u20133359. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-3418 (2019).","journal-title":"Cancer Res."},{"key":"46678_CR33","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8855423","volume":"2020","author":"HF Lu","year":"2020","unstructured":"Lu, H. F. et al. Pharmacogenomics study for raloxifene in postmenopausal female with osteoporosis. Dis. Mark. 2020, 8855423. https:\/\/doi.org\/10.1155\/2020\/8855423 (2020).","journal-title":"Dis. Mark."},{"issue":"3","key":"46678_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1009254","volume":"17","author":"C Lesseur","year":"2021","unstructured":"Lesseur, C. et al. Genome-wide association meta-analysis identifies pleiotropic risk loci for aerodigestive squamous cell cancers. PLoS Genet. 17(3), e1009254. https:\/\/doi.org\/10.1371\/journal.pgen.1009254 (2021).","journal-title":"PLoS Genet."},{"key":"46678_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12675","author":"K Lawrenson","year":"2016","unstructured":"Lawrenson, K. et al. Gayther, Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus. Nat. Commun. https:\/\/doi.org\/10.1038\/ncomms12675 (2016).","journal-title":"Nat. Commun."},{"issue":"6151","key":"46678_CR36","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/331091a0","volume":"331","author":"V Gigu\u00e8re","year":"1988","unstructured":"Gigu\u00e8re, V., Yang, N., Segui, P. & Evans, R. M. Identification of a new class of steroid hormone receptors. Nature 331(6151), 91\u201394. https:\/\/doi.org\/10.1038\/331091a0 (1988).","journal-title":"Nature"},{"issue":"5","key":"46678_CR37","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/s1043-2760(02)00592-1","volume":"13","author":"V Gigu\u00e8re","year":"2002","unstructured":"Gigu\u00e8re, V. To ERR in the estrogen pathway. Trend. Endocrinol. Metab. 13(5), 220\u2013225. https:\/\/doi.org\/10.1016\/s1043-2760(02)00592-1 (2002).","journal-title":"Trend. Endocrinol. Metab."},{"issue":"6","key":"46678_CR38","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1210\/er.2008-0017","volume":"29","author":"V Gigu\u00e8re","year":"2008","unstructured":"Gigu\u00e8re, V. Transcriptional control of energy homeostasis by the estrogen-related receptors. Endocr. Rev. 29(6), 677\u2013696. https:\/\/doi.org\/10.1210\/er.2008-0017 (2008).","journal-title":"Endocr. Rev."},{"issue":"8","key":"46678_CR39","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.7150\/ijbs.57623","volume":"17","author":"FN Li","year":"2021","unstructured":"Li, F. N. et al. ESRRA promotes gastric cancer development by regulating the CDC25C\/CDK1\/CyclinB1 pathway via DSN1. Int. J. Biol. Sci. 17(8), 1909\u20131924. https:\/\/doi.org\/10.7150\/ijbs.57623 (2021).","journal-title":"Int. J. Biol. Sci."},{"key":"46678_CR40","doi-asserted-by":"publisher","DOI":"10.1177\/1533033821992083","volume":"20","author":"S Wang","year":"2021","unstructured":"Wang, S. & Huo, X. Comprehensive analysis of ESRRA in endometrial cancer. Technol. Cancer Res. Treat. 20, 1080259731. https:\/\/doi.org\/10.1177\/1533033821992083 (2021).","journal-title":"Technol. Cancer Res. Treat."},{"issue":"6","key":"46678_CR41","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1111\/febs.16750","volume":"290","author":"M Tripathi","year":"2023","unstructured":"Tripathi, M. & Singh, B. K. Metabolic switching of estrogen-related receptor alpha in breast cancer aggression. FEBS J. 290(6), 1473\u20131476. https:\/\/doi.org\/10.1111\/febs.16750 (2023).","journal-title":"FEBS J."},{"issue":"20","key":"46678_CR42","doi-asserted-by":"publisher","first-page":"4096","DOI":"10.1002\/pmic.201000717","volume":"11","author":"JJ Fischer","year":"2011","unstructured":"Fischer, J. J. et al. SAHA Capture Compound--A novel tool for the profiling of histone deacetylases and the identification of additional vorinostat binders. Proteomics 11(20), 4096\u20134104. https:\/\/doi.org\/10.1002\/pmic.201000717 (2011).","journal-title":"Proteomics"},{"issue":"3","key":"46678_CR43","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.3892\/or.2018.6947","volume":"41","author":"P Wu","year":"2019","unstructured":"Wu, P. et al. Identification and validation of alternative splicing isoforms as novel biomarker candidates in hepatocellular carcinoma. Oncol. Rep. 41(3), 1929\u20131937. https:\/\/doi.org\/10.3892\/or.2018.6947 (2019).","journal-title":"Oncol. Rep."},{"key":"46678_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2021.100743","volume":"54","author":"JQ Wang","year":"2021","unstructured":"Wang, J. Q. et al. Multidrug resistance proteins (MRPs): Structure, function and the overcoming of cancer multidrug resistance. Drug Resist. Updat. 54, 100743. https:\/\/doi.org\/10.1016\/j.drup.2021.100743 (2021).","journal-title":"Drug Resist. Updat."},{"issue":"4","key":"46678_CR45","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1208\/s12248-015-9757-1","volume":"17","author":"YK Zhang","year":"2015","unstructured":"Zhang, Y. K., Wang, Y. J., Gupta, P. & Chen, Z. S. Multidrug resistance proteins (MRPs) and cancer therapy. AAPS J. 17(4), 802\u2013812. https:\/\/doi.org\/10.1208\/s12248-015-9757-1 (2015).","journal-title":"AAPS J."},{"key":"46678_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.gep.2020.119147","volume":"38","author":"A Cheong","year":"2020","unstructured":"Cheong, A., Lingutla, R. & Mager, J. Expression analysis of mammalian mitochondrial ribosomal protein genes. Gene Expr. Patterns 38, 119147. https:\/\/doi.org\/10.1016\/j.gep.2020.119147 (2020).","journal-title":"Gene Expr. Patterns"},{"issue":"24","key":"46678_CR47","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.21037\/atm-22-5820","volume":"10","author":"L Li","year":"2022","unstructured":"Li, L. et al. Screening key genes related to neuropathic pain-induced depression through an integrative bioinformatics analysis. Ann. Transl. Med. 10(24), 1348. https:\/\/doi.org\/10.21037\/atm-22-5820 (2022).","journal-title":"Ann. Transl. Med."},{"key":"46678_CR48","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0000000000001293","author":"Y Kim","year":"2016","unstructured":"Kim, Y. et al. Morphine suppresses lung cancer cell proliferation through the interaction with opioid growth factor receptor: an in vitro and human lung tissue study. Anesth. Analg. https:\/\/doi.org\/10.1213\/ANE.0000000000001293 (2016).","journal-title":"Anesth. Analg."},{"key":"46678_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106718","volume":"84","author":"N Liu","year":"2020","unstructured":"Liu, N. et al. Low-dose naltrexone inhibits the epithelial-mesenchymal transition of cervical cancer cells in vitro and effects indirectly on tumor-associated macrophages in vivo. Int. Immunopharmacol. 84, 106718. https:\/\/doi.org\/10.1016\/j.intimp.2020.106718 (2020).","journal-title":"Int. Immunopharmacol."},{"key":"46678_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/jof7100856","author":"C de la Horra","year":"2021","unstructured":"de la Horra, C. et al. Update on Dihydropteroate Synthase (DHPS) Mutations in Pneumocystis jirovecii. J. Fung. https:\/\/doi.org\/10.3390\/jof7100856 (2021).","journal-title":"J. Fung."},{"issue":"9","key":"46678_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-020-00271-1","volume":"9","author":"C Wang","year":"2020","unstructured":"Wang, C. et al. Extracellular signal-regulated kinases associate with and phosphorylate DHPS to promote cell proliferation. Oncogenesis 9(9), 85. https:\/\/doi.org\/10.1038\/s41389-020-00271-1 (2020).","journal-title":"Oncogenesis"},{"issue":"6","key":"46678_CR52","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s13402-014-0201-9","volume":"37","author":"A Bandino","year":"2014","unstructured":"Bandino, A., Geerts, D., Koster, J. & Bachmann, A. S. Deoxyhypusine synthase (DHPS) inhibitor GC7 induces p21\/Rb-mediated inhibition of tumor cell growth and DHPS expression correlates with poor prognosis in neuroblastoma patients. Cell Oncol. (Dordr) 37(6), 387\u2013398. https:\/\/doi.org\/10.1007\/s13402-014-0201-9 (2014).","journal-title":"Cell Oncol. (Dordr)"},{"issue":"2","key":"46678_CR53","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.cmet.2019.05.003","volume":"30","author":"DJ Puleston","year":"2019","unstructured":"Puleston, D. J. et al. Polyamines and eIF5A hypusination modulate mitochondrial respiration and macrophage activation. Cell Metab. 30(2), 352\u2013363. https:\/\/doi.org\/10.1016\/j.cmet.2019.05.003 (2019).","journal-title":"Cell Metab."},{"issue":"1","key":"46678_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32788-x","volume":"13","author":"J Zhou","year":"2022","unstructured":"Zhou, J. et al. Spermidine-mediated hypusination of translation factor EIF5A improves mitochondrial fatty acid oxidation and prevents non-alcoholic steatohepatitis progression. Nat. Commun. 13(1), 5202. https:\/\/doi.org\/10.1038\/s41467-022-32788-x (2022).","journal-title":"Nat. Commun."},{"issue":"9","key":"46678_CR55","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1016\/j.cmet.2021.08.003","volume":"33","author":"E Anderson-Baucum","year":"2021","unstructured":"Anderson-Baucum, E. et al. Deoxyhypusine synthase promotes a pro-inflammatory macrophage phenotype. Cell Metab. 33(9), 1883\u20131893. https:\/\/doi.org\/10.1016\/j.cmet.2021.08.003 (2021).","journal-title":"Cell Metab."},{"key":"46678_CR56","doi-asserted-by":"publisher","DOI":"10.1101\/2023.04.24.537996","author":"CT Connors","year":"2023","unstructured":"Connors, C. T. et al. Deoxyhypusine synthase is required for the translational regulation of pancreatic beta cell maturation. bioRxiv https:\/\/doi.org\/10.1101\/2023.04.24.537996 (2023).","journal-title":"bioRxiv"},{"key":"46678_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara, K. et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat. Commun. 4, 2612. https:\/\/doi.org\/10.1038\/ncomms3612 (2013).","journal-title":"Nat. Commun."},{"issue":"2","key":"46678_CR58","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.cell.2020.03.013","volume":"181","author":"D Park","year":"2020","unstructured":"Park, D., Sahai, E. & Rullan, A. Snapshot: Cancer-associated fibroblasts. Cell 181(2), 486. https:\/\/doi.org\/10.1016\/j.cell.2020.03.013 (2020).","journal-title":"Cell"},{"issue":"4","key":"46678_CR59","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s41568-023-00549-7","volume":"23","author":"M Tsoumakidou","year":"2023","unstructured":"Tsoumakidou, M. The advent of immune stimulating CAFs in cancer. Nat. Rev. Cancer 23(4), 258\u2013269. https:\/\/doi.org\/10.1038\/s41568-023-00549-7 (2023).","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"46678_CR60","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/JLB.4RI0818-311R","volume":"106","author":"CE Olingy","year":"2019","unstructured":"Olingy, C. E., Dinh, H. Q. & Hedrick, C. C. Monocyte heterogeneity and functions in cancer. J. Leukoc. Biol. 106(2), 309\u2013322. https:\/\/doi.org\/10.1002\/JLB.4RI0818-311R (2019).","journal-title":"J. Leukoc. Biol."},{"issue":"6","key":"46678_CR61","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.it.2017.04.002","volume":"38","author":"S Halle","year":"2017","unstructured":"Halle, S., Halle, O. & Forster, R. Mechanisms and dynamics of t cell-mediated cytotoxicity in vivo. Trend. Immunol. 38(6), 432\u2013443. https:\/\/doi.org\/10.1016\/j.it.2017.04.002 (2017).","journal-title":"Trend. Immunol."},{"key":"46678_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2023.156234","volume":"168","author":"C Bailly","year":"2023","unstructured":"Bailly, C. Etoposide: A rider on the cytokine storm. Cytokine 168, 156234. https:\/\/doi.org\/10.1016\/j.cyto.2023.156234 (2023).","journal-title":"Cytokine"},{"issue":"1 Suppl","key":"46678_CR63","first-page":"266","volume":"67","author":"GJ Sledge","year":"1991","unstructured":"Sledge, G. J. Etoposide in the management of metastatic breast cancer. Cancer-Am. Cancer Soc. 67(1 Suppl), 266\u2013270 (1991).","journal-title":"Cancer-Am. Cancer Soc."},{"issue":"6 Suppl 13","key":"46678_CR64","first-page":"67","volume":"19","author":"CR Nichols","year":"1992","unstructured":"Nichols, C. R. Role of etoposide in treatment of breast cancer. Semin. Oncol. 19(6 Suppl 13), 67\u201371 (1992).","journal-title":"Semin. Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46678-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46678-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46678-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T11:02:13Z","timestamp":1781694133000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46678-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,18]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["46678"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-46678-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,18]]},"assertion":[{"value":"20 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing of interest"}},{"value":"The present study has been performed by the Declaration of Helsinki and was approved by the Ethics.Approval was granted by the the General Hospital of Ning Xia Medical University, and the approval number and date of approval are [KYLL-2023-0280] and [October 25, 2023]. Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"18739"}}